Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 4;8(6):1284-1289.
doi: 10.1016/j.jseint.2024.06.010. eCollection 2024 Nov.

Industry affiliation influence on randomized controlled trials for platelet-rich plasma in the treatment of lateral epicondylitis: a systematic review

Justin B Castonguay  1 , Jacob L Kotlier  2 , Amir Fathi  2 , Frank A Petrigliano  2 , Joseph N Liu  3
Affiliations

Industry affiliation influence on randomized controlled trials for platelet-rich plasma in the treatment of lateral epicondylitis: a systematic review

Justin B Castonguay et al. JSES Int. .

Abstract

Background: Explicit funding and industry affiliation are believed to potentially impact medical research. There have been an increasing number of studies that have evaluated this relationship. The purpose of this study is to determine whether industry affiliation influences the outcomes of randomized controlled trials that investigate the effectiveness of platelet-rich plasma (PRP) in the treatment of lateral epicondylitis.

Methods: A search of PubMed, SPORTDiscus, and SCOPUS was performed using the search terms "lateral epicondylitis" and "platelet-rich plasma" as well as "tennis elbow" and "platelet-rich plasma." Only studies from 2010 to present were considered. Final texts were then analyzed for industry affiliation and treatment efficacy. When determining whether a study was industry-affiliated, explicit financial supporters of the study, stated conflicts of interest, American Academy of Orthopaedic Surgeons disclosures, and the Centers for Medicare and Medicaid Services open payments database were assessed. Study outcomes were categorized as favorable, analogous, or unfavorable based on achieving a statistically significant (P < .05) comparison between PRP and control.

Results: A total of 26 studies were used. Of these, 20 were industry nonaffiliated and 6 were industry affiliated. There were 15 studies (2 affiliated and 13 nonaffiliated) that reported PRP as favorable compared to the comparison (corticosteroid, analogous whole blood, or normal saline). The endpoints were 6 and 12 months after the use of PRP or the comparison. Quantitative data analysis yielded results that were not statistically significant between industry-nonaffiliated and affiliated groups. The P values for 6-month visual analog scale, 12-month visual analog scale, 6-month disabilities of the arm, shoulder, and hand, 12-month disabilities of the arm, shoulder, and hand, 6-month patient-related tennis elbow evaluation, and 12-month patient-related tennis elbow evaluation were 0.577, 0.635, 0.554, 0.465, 0.273, and 0.157, respectively.

Conclusion: Despite our results indicating that industry affiliation does not have an impact on outcomes of randomized controlled trials examining the treatment of lateral epicondylitis with PRP, it is important for future studies to evaluate affiliations when making treatment recommendations.

Keywords: Extensor carpi radialis brevis; Industry affiliation; Lateral epicondylitis; PRP; Platelet-rich plasma; Tennis elbow.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Inclusion criteria in the PRISMA flowsheet. This is a summary of the exclusion criteria listed in the manuscript. It shows that initially there were 533 studies from PubMed, SPORTDiscus, and Scopus. After duplicates were removed, abstract/title screening, full-text screening, and exclusion criteria, it shows the total studies used for analysis. PRISMA, Preferred Reporting Items for Systemic Reviews and Meta-Analysis; PRP, platelet-rich plasma; RCT, randomized controlled trial.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Amiri A.R., Kanesalingam K., Cro S., Casey A.T. Does source of funding and conflict of interest influence the outcome and quality of spinal research? Spine J. 2014;14:308–314. doi: 10.1016/j.spinee.2013.10.047. - DOI - PubMed
    1. Arora K.K., Kapila R., Kapila S., Patra A., Chaudhary P., Singal A. Management of lateral epicondylitis: a prospective comparative study comparing the local infiltrations of leucocyte enriched platelet-rich plasma (L-aPRP), glucocorticoid and normal saline. Malays Orthop J. 2022;16:58–69. doi: 10.5704/MOJ.2203.009. - DOI - PMC - PubMed
    1. Behera P., Dhillon M., Aggarwal S., Marwaha N., Prakash M. Leukocyte-poor platelet-rich plasma versus bupivacaine for recalcitrant lateral epicondylar tendinopathy. J Orthop Surg. 2015;23:6–10. doi: 10.1177/230949901502300102. - DOI - PubMed
    1. Chou K., Gazendam A., Vemulakonda J., Bhandari M. Failure to disclose industry funding impacts outcomes in randomized controlled trials of platelet-rich plasma. Knee Surg Sports Traumatol Arthrosc. 2023;31:626–631. doi: 10.1007/s00167-022-07118-9. - DOI - PubMed
    1. Creaney L., Wallace A., Curtis M., Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011;45:966–971. doi: 10.1136/bjsm.2010.082503. - DOI - PubMed

LinkOut - more resources